The primary goal of this Anti-hypertensive Drugs Market report is to maintain the record of Unusual growth strategies adopted by various companies are creating new standards for competition in the Anti-hypertensive Drugs market. Businesses around the world are aiming at increasing their profit margin and establishing a stronghold in the market. The impact of prevailing regulatory scenario on both regional and worldwide Anti-hypertensive Drugs market is provided in detail in the report.

Get Sample Copy of Anti-hypertensive Drugs Market Report @

Key Market Trends:

Diuretics is Expected to Hold a Significant Market Share in the Therapeutic Class

Thiazide diuretics are the cornerstone of treatment for hypertension in most patients. Hydrochlorothiazide is the most commonly used thiazide diuretic in the United States. The Joint National Committee on the prevention, detection, evaluation, and treatment of high blood pressure recommends thiazide-type diuretics to be one of the preferred drug treatments for hypertension, whether used on its own or along with other antihypertensive drugs, such as calcium channel blockers. Moreover, it was also noted that more than one-third of the adults affected by hypertension were reported to take diuretics.

North America Dominates the Market and is Expected to do Same during the Forecast Period

According to the AHA (American heart association), 74.9% of hypertension patients are currently undergoing treatment, and only 52.2% of patients have it under control. AHA projection shows that by 2030, about 41.4% of adults in the United States are expected to have hypertension. The demand for prompt and accurate diagnosis, and treatment of hypertension, identifying people predisposed to the disease, presence of technically advanced healthcare infrastructure, and management of the prognosis of the disease are some of the key market drivers of the North American anti-hypertension market.

Anti-hypertensive Drugs Market Covers Key Players:

  • Astrazeneca PLC
  • Boehringer Ingelheim
  • Daiichi Sankyo Company Limited
  • Johnson & Johnson Ltd
  • Lupin Limited
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Ranbaxy Laboratories Limited
  • Sanofi SA

    Ask for Discount at

    Geographical Landscape:

    This Report Focuses on the Anti-hypertensive Drugs in the market, especially in North America, China, Europe, Japan, Southeast Asia, India. This report categorizes the market based on manufacturers, regions, type, and application

    Market Overview:

  • The anti-hypertensive drugs market is expected to witness a CAGR of 4.5%, during the forecast period. Certain factors that are driving the market growth include increasing prevalence of hypertension, growing initiatives by private and government organizations, and rising awareness about hypertension.
  • The prevalence of hypertension has observed a significant rise over the past few years. Generally, blood pressure rises and falls throughout the day. However, it can damage one’s heart and result in health problems, if it stays high for a long time. High blood pressure is called hypertension. High blood pressure is the most harmful factor when it comes to the risk of heart disease and stroke, which is the leading cause of death in the United States. According to the CDC (Centers for Disease Control and Prevention), about 75 million American adults (32%) have high blood pressure (hypertension), but only about half (54%) of people with high blood pressure have their condition under control. High blood pressure was a primary and contributing cause of death for more than 410,000 American citizens, in 2014. CDC also states that high blood pressure costs the nation USD 48.6 billion every year. This total includes the medications to treat high blood pressure, cost of health care services, and missed days of work.
  • However, even though most blood pressure medicines are easy to administrate, almost all medicines show certain side effects. Some common side effects of the antihypertensive medicines include cough, diarrhea or constipation, dizziness or lightheadedness, erection problems, feeling nervous, feeling tired, weak, drowsy, or a lack of energy, headache, skin rash, nausea or vomiting, and weight loss or gain without trying. These various side effects associated with the antihypertensive drugs are expected to hinder the growth of the market, over the forecast period.

    Report Highlights:

    – The report provides a detailed analysis on current and future market trends to identify the investment opportunities

    – Market forecasts till 2024, using estimated market values as the base numbers

    – Key market trends across the business segments, Regions and Countries

    – Key developments and strategies observed in the market

    – Market Dynamics such as Drivers, Restraints, Opportunities and other trends

    – In-depth company profiles of key players and upcoming prominent players

    – Growth prospects among the emerging nations through 2024

    – Anti-hypertensive Drugs Market opportunities and recommendations for new investments

    Price Of Report: $ 4250 (SUL)

    Purchase Anti-hypertensive Drugs Market Report @

    Detailed TOC of Anti-hypertensive Drugs Market Research Report 2019 – 2024:

    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study



    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Increasing Prevalence of Hypertension
    4.2.2 Growing Initiatives by Private and Government Organizations
    4.2.3 Rising Awareness about Hypertension
    4.3 Market Restraints
    4.3.1 Multiple Major Drug Patent Expiration
    4.3.2 Side-effects of Treatment Options
    4.3.3 Rise in Non-pharmacological Therapy
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5.1 Therapeutic Class
    5.1.1 Diuretics
    5.1.2 Angiotensin Converting Enzyme (ACE) Inhibitors
    5.1.3 Angiotensin Receptor Blockers (ARBs)
    5.1.4 Beta Blockers
    5.1.5 Alpha Blockers
    5.1.6 Renin Inhibitors
    5.1.7 Calcium Channel Blockers
    5.1.8 Other Therapeutic Classes
    5.2 Geography
    5.2.1 North America United States Canada Mexico
    5.2.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
    5.2.3 Asia-Pacific China Japan India Australia South korea Rest of Asia-Pacific
    5.2.4 Middle East & Africa GCC South Africa Rest of Middle East & Africa
    5.2.5 South America Brazil Argentina Rest of South America

    6.1 Company Profiles
    6.1.1 Astrazeneca PLC
    6.1.2 Boehringer Ingelheim
    6.1.3 Daiichi Sankyo Company Limited
    6.1.4 Johnson & Johnson Ltd
    6.1.5 Lupin Limited
    6.1.6 Merck & Co. Inc.
    6.1.7 Novartis AG
    6.1.8 Pfizer Inc.
    6.1.9 Ranbaxy Laboratories Limited
    6.1.10 Sanofi SA


    About Industry Research:

    Industry Research is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in-depth market research. We are one of the top report resellers in the market, dedicated to bringing you an ingenious concoction of data parameters.

    Contact Us:

    Name: Ajay More

    Organization: Industry Research

    Phone: +44 20 3239 8187 / +14242530807

    Email: [email protected]

    Our latest Report: Server Motherboard Market 2019 Offers Newest Industry Data, Industry Future Trends, Sales, Revenue, Growth Rate by Types and Applications Forecast till 2025